Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The respiratory syncytial virus prefusion-F glycoprotein is an essential viral surface protein responsible for mediating entry into host cells through direct membrane fusion. Its metastable trimeric structure presents unique antigenic surfaces that elicit robust neutralizing antibody responses during natural infection—making it an optimal target for vaccine design. Stabilized versions capturing this conformation underpin current advances in effective prophylactic strategies against severe RSV disease across age groups.
Neutralizing antibody binding to preF conformation, blocking membrane fusion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory Syncytial Virus F Glycoprotein (Prefusion Conformation) (RSV F (preF)).